Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Chromogranin A as an Alternative to 5-Hydroxyindoleacetic Acid in the Evaluation of Symptoms during Treatment of Patients with Neuroendocrine Tumors
Neuroendocrinology, 10/08/08
Korse CM et al. - Stronger correlations of CgA compared to 5-HIAA with physical functioning and wellbeing, the convenience of measuring in blood, as well as the prognostic value of CgA for survival, makes CgA the recommended marker in the management of patients with metastatic NETs.
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
Acta Neurologica Scandinavica, 12/02/09
Bacitracin-Sensitive Aminopeptidase(s) Degradation of Methionine5-Enkephalin by Human Brain Putamen and Hippocampus Preparations: Inhibition by Phenothiazine Drugs
American Journal of Therapeutics, 12/02/09
Ifosfamide-induced encephalopathy and movement disorder
Pediatric Blood & Cancer, 12/02/09
Today in Patient Counseling...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
Acta Neurologica Scandinavica, 12/02/09
Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Archives of Dermatology, 11/25/09
Male involvement in antenatal HIV counseling and testing: exploring mens perceptions in rural Malawi
AIDS Care, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


